首页> 美国卫生研究院文献>BMC Gastroenterology >Dexmedetomidine is safe and reduces the additional dose of midazolam for sedation during endoscopic retrograde cholangiopancreatography in very elderly patients
【2h】

Dexmedetomidine is safe and reduces the additional dose of midazolam for sedation during endoscopic retrograde cholangiopancreatography in very elderly patients

机译:右美托咪定是安全的可减少非常年老患者的内镜逆行胰胆管造影术中镇静时使用的咪达唑仑的额外剂量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEndoscopic retrograde cholangiopancreatography (ERCP) often requires deep sedation. Dexmedetomidine, a highly selective α2-adrenoceptor agonist with sedative activity and minimal effects on respiration, has recently been widely used among patients in the intensive care unit. However, its use in endoscopic procedures in very elderly patients is unclear. In this study, we retrospectively investigated the safety and efficacy of dexmedetomidine sedation during ERCP.
机译:背景内镜逆行胰胆管造影术(ERCP)通常需要深度镇静。右美托咪定是一种高度镇静的α2-肾上腺素受体激动剂,具有镇静活性,对呼吸的影响很小,最近已在重症监护病房的患者中广泛使用。但是,对于非常年老的患者,其在内窥镜检查中的应用尚不清楚。在这项研究中,我们回顾性研究了ERCP期间右美托咪定镇静的安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号